Literature DB >> 24943857

[Effect of intravenous dexketoprofen use on postoperative analgesic consumption in patients with lumbar disc surgery].

Ebru Kelsaka1, Fuat Güldoğuş2, Erhan Cetinoğlu2.   

Abstract

OBJECTIVES: The objective of this study was to evaluate the postoperative analgesic effect of a preemptive, single-dose intravenous dexketoprofen administration in patients undergoing lumbar microdiscectomy.
METHODS: A total of 50 ASA I-II patients candidate to laminectomy were included in this study. They were divided in two groups. Patients in Group A were given 50 mg (2 mL) dexketoprofen and those in Group K 2 mL normal saline intravenously by a blinded anesthesia physician, 10 minutes before the start of intervention. All cases underwent general anesthesia. All patients received postoperative patient-controlled analgesia with tramadol. The VAS scores 1, 4, 8, 16 and 24 hours following the operation, sedation and patient satisfaction scores and tramadol consumption were evaluated.
RESULTS: VAS scores recorded during the first 8 postoperative hours and total tramadol amounts were lower, and the patient satisfaction scores higher, in patients given dexketoprofen than control group. Sedation scores and side effects were similar in both groups.
CONCLUSION: Single-dose preemptive intravenous dexketoprofen provides effective analgesia especially in the first 8 postoperative hours, reducing tramadol use.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24943857     DOI: 10.5505/agri.2014.47550

Source DB:  PubMed          Journal:  Agri        ISSN: 1300-0012


  2 in total

1.  Effects of Addition of Preoperative Intravenous Ibuprofen to Pregabalin on Postoperative Pain in Posterior Lumbar Interbody Fusion Surgery.

Authors:  Hüseyin Ulaş Pınar; Ömer Karaca; Fatma Karakoç; Rafi Doğan
Journal:  Pain Res Manag       Date:  2017-08-16       Impact factor: 3.037

2.  Effects of dexmedetomidine and dexketoprofen on the conduction block of rat sciatic nerve.

Authors:  Sengal Bagci Taylan; Hulagu Bariskaner
Journal:  Neural Regen Res       Date:  2020-05       Impact factor: 5.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.